The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia.

Department of Medicine, University of California, San Francisco, USA.
The Journal of Clinical Endocrinology and Metabolism (Impact Factor: 6.31). 02/2009; 94(4):1137-44. DOI: 10.1210/jc.2008-1588
Source: PubMed

ABSTRACT Leptin deficiency is associated with dyslipidemia and insulin resistance in animals and humans with lipoatrophy; leptin replacement ameliorates these abnormalities.
The objective of the study was to evaluate the effects of leptin therapy in lipoatrophic HIV-infected patients with dyslipidemia and hypoleptinemia.
This was a 6-month, open-label, proof-of-principle pilot study.
Metabolic ward studies were performed before and 3 and 6 months after leptin treatment.
Participants included eight HIV-infected men with lipoatrophy, fasting triglycerides greater than 300 mg/dl, and serum leptin less than 3 ng/ml.
Recombinant human leptin was given by sc injection (0.01 mg/kg and 0.03 mg/kg twice daily for successive 3 month periods).
Measures included fat distribution by magnetic resonance imaging and dual-energy X-ray absorptiometry; fasting lipids; insulin sensitivity by euglycemic hyperinsulinemic clamp; endogenous glucose production, gluconeogenesis, glycogenolysis, and whole-body lipolysis by stable isotope tracer studies; oral glucose tolerance testing; liver fat by proton magnetic resonance spectroscopy; and safety.
Visceral fat decreased by 32% (P = 0.001) with no changes in peripheral fat. There were significant decreases in fasting total (15%, P = 0.012), direct low-density lipoprotein (20%, P = 0.002), and non-high-density lipoprotein (19%, P = 0.005) cholesterol. High-density lipoprotein cholesterol increased. Triglycerides, whole-body lipolysis, and free fatty acids decreased during fasting and hyperinsulinemia. Fasting insulin decreased. Endogenous glucose production decreased during fasting and hyperinsulinemia, providing evidence of improved hepatic insulin sensitivity. Leptin was well tolerated but decreased lean mass.
Leptin treatment was associated with marked improvement in dyslipidemia. Hepatic insulin sensitivity improved and lipolysis decreased. Visceral fat decreased with no exacerbation of peripheral lipoatrophy. Results from this pilot study suggest that leptin warrants further study in patients with HIV-associated lipoatrophy.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The treatment of metabolic disease is becoming an increasingly important component of the long-term management of patients with well controlled HIV on antiretroviral therapy (ART). Metabolic diseases probably develop at the intersection of traditional risk factors (such as obesity, tobacco use, and genetic predisposition) and HIV-specific and ART-specific contributors (including chronic inflammation and immune activation). This Review discusses present knowledge on adipose tissue dysfunction, insulin-glucose homoeostasis, lipid disturbances, and cardiovascular disease risk in people with HIV on ART. Although new antiretroviral drugs are believed to induce fewer short-term metabolic perturbations than do older drugs, the long-term effects of these drugs are not fully understood. Additionally, patients remain at increased risk of cardiovascular disease and other metabolic comorbidities. Research and treatment should focus on selection of ART that is both virologically effective and has minimum metabolic effects, minimisation of traditional risk factors for metabolic disease, and development of novel therapies to treat metabolic disease in patients with HIV, including use of anti-inflammatory and immunomodulatory drugs.
    The Lancet Infectious Diseases 11/2013; 13(11):964-75. · 19.45 Impact Factor
  • Endocrine Practice 03/2010; · 2.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A fiber sensor configuration suitable for discrimination of temperature and strain is presented. The sensor head is composed of two parallel concatenated Sagnac loops based on character-1 shaped polarization-maintaining fiber (PMF). The two Sagnac loops include different sections of character-1 shaped PMFs, and show different sensitivity to temperature and strain. By monitoring the wavelength shift of the two dips in the transmission spectrum, simultaneous measurement of temperature and strain is obtained. The sensitivity for strain and temperature are measured to be 14.46pm and −0.54nm.
    Optics Communications 02/2012; · 1.54 Impact Factor


Available from
May 22, 2014